Search Results 51-60 of 16093 for pharmacogenetics

  1. Comparison of Pharmacogenomic Testing Results Across Companies - Mayo Clinic

    The purpose of this study is to: To evaluate whether the genotypic and phenotypic results for a single subject are the same among companies offering ...

  2. Science Saturday: Moving pharmacogenomics into everyday clinical practice

    After nearly half a century of research, Mayo Clinic is a leader in moving pharmacogenomics into clinical practice. This year pharmacogenomics test results ...

  3. Matthew P. Goetz, M.D. - Doctors and Medical Staff - Mayo Clinic

    Chair2024 Scientific Program Subcommittee, Pharmacology, Pharmacogenetics and Pharmacogenomics Subcommittee, Experimental and Molecular Therapeutics Section.

  4. Andres J. Acosta, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    The study of genetic polymorphisms associated with gastrointestinal traits and obesity therapy, known as pharmacogenetics and novel pharmacotherapeutics, are a ...

  5. Pharmacogenomics (PGx) Results and Clinical Data of Established Patients with Liver Disease to Assess Current and Future Therapeutic Relevance of PGx Testing - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing in established patients with ...

  6. Experiential Pharmacogenomic Education for Providers - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

  7. A Study of Pharmacogenomics (PGx) Results and Clinical Data of Patients in the Palliative Medicine Clinic to Assess Current and Future Therapeutic Relevance - Mayo Clinic

    About this study. The goal of this study is to examine the current and (potential) future therapeutic relevance of PGx testing for a group of patients in ...

  8. A Study to Evaluate the Pharmacist Role and Pharmacogenomics in the Care of Seriously Ill Patients - Mayo Clinic

    About this study · The impact that a clinical pharmacist and pharmacogenomic testing has on symptom management; · Patient perceptions, satisfaction and behaviors ...

  9. PREemptive Pharmacogenomic testing for prevention of Adverse drug REactions - Mayo Clinic

    About this study. The purpose of this study is to determine whether the implementation of pre-emptive PGx[HSR1] testing of a panel of clinically relevant ...

  10. Pharmacogenomics and the Potential for Utilization of Testing Results for Patient Care in the Cardiac Surgical Intensive Care Unit - Mayo Clinic

    About this study. The overall goals of this pilot study are to: (1) describe pharmacogenomics (PGx) testing results and identify PGx variants that may ...